IL17A and arthritic joint disease: Tan’s research shows that (32), curculigo glucoside has a significant anti-arthritis effect, which can significantly inhibit the proliferation of MH7A cells, improve the arthritis symptoms of type II collagen-induced arthritis (CIA) rats and reduce the levels of inflammatory factors (TNF-α, IL-1β, IL-6, IL-10, IL-12 and IL-17A).